Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluation of safety of Zirconium-89 (89Zr)- rituximab chimeric anti-CD20 antibody for PET/CT imaging and dosimetry. Evaluation of safety of Yttrium-90 (90Y)-rituximab chimeric anti-CD20 antibody radioimmunotherapy in patients with B-cell lymphoma who are in partial remission or progressive disease
Critère d'inclusion
- CD20 positive Lymphoma